SEPPIC launches SEPIWHITE MSH QD to meet regulatory requirements in Japan

  • October 8, 2013
  • 2 mins of read time

SEPPIC launches SEPIWHITE MSH QD to meet regulatory requirements in Japan

SEPPIC, a major player in the market for active cosmetics ingredients, is today launching SEPIWHITE MSH QD, which enables the efficiency of QD whitening formulas to be doubled.

SEPIWHITE MSH QD is an active skin whitening ingredient which has now been registered as an adjuvant for Quasi-Drug formulas by the Japanese Ministry of Health and Well-Being. This represents the result of a long-term project involving efforts from a number of SEPPIC teams in both Asia and Europe.
The registration of SEPIWHITE MSH QD enables SEPPIC to respond to a growing global demand for whitening agents. The market for these products is expected to reach $19.8 billion by 2018, driven by high demand in Asia and especially Japan.

When combined with a standard whitening agent, SEPIWHITE MSH QD doubles the agent’s whitening properties. It halves the amount of melanin in the skin relative to the effect of the agent alone and enables visible results to be achieved in a shorter time (in-vivo test at 0.2% of SEPIWHITE MSH QD). This high-performance combination met the approval of a panel of Asian consumers.

SEPIWHITE MSH QD is a lipoaminoacid which acts as a biovector for phenylalanine. A pure molecule with no preservative, it is produced in an environmentally friendly chemical process and complies with the Ecocert standard. The colorless compound is included at 0.2% in all types of anti-aging and whitening products.

“SEPPIC has proved its expertise once again with an active ingredient which enhances the performance of whitening formulas for the Japanese Quasi-Drug market” says Yohanna Sander, Head of Anti-Aging Products.